Association of Serum Phosphorus Levels With QT Prolongation in Patients With End‐Stage Kidney Disease: Insights From the Analysis of Peritoneal Dialysis Patients
Sho Sasaki, Kiichiro Fujisaki, Hikaru Uematsu, Masato Nishimura, Toshiaki Nakano, Masanori Abe et al. Association of Serum Phosphorus Levels With QT Prolongation in Patients With End‐Stage Kidney Disease: Insights From the Analysis of Peritoneal Dialysis Patients. // Therapeutic Apheresis and Dialysis. – 2026. – DOI: 10.1002/1744-9987.70184. – URL: https://onlinelibrary.wiley.com/doi/10.1002/1744-9987.70184?af=R
Sho Sasaki, Kiichiro Fujisaki, Hikaru Uematsu, Masato Nishimura, Toshiaki Nakano, Masanori Abe, Norio Hanafusa, & Nobuhiko Joki (2026). Association of Serum Phosphorus Levels With QT Prolongation in Patients With End‐Stage Kidney Disease: Insights From the Analysis of Peritoneal Dialysis Patients. Therapeutic Apheresis and Dialysis. https://doi.org/10.1002/1744-9987.70184
Sho Sasaki, et al. “Association of Serum Phosphorus Levels With QT Prolongation in Patients With End‐Stage Kidney Disease: Insights From the Analysis of Peritoneal Dialysis Patients.” Therapeutic Apheresis and Dialysis, 2026. doi:10.1002/1744-9987.70184.
@article{Sasaki2026,
title = {Association of Serum Phosphorus Levels With QT Prolongation in Patients With End‐Stage Kidney Disease: Insights From the Analysis of Peritoneal Dialysis Patients},
author = {Sasaki, Sho and Fujisaki, Kiichiro and Uematsu, Hikaru and Nishimura, Masato and Nakano, Toshiaki and Abe, Masanori and Hanafusa, Norio and Joki, Nobuhiko},
journal = {Therapeutic Apheresis and Dialysis},
year = {2026},
doi = {10.1002/1744-9987.70184},
url = {https://onlinelibrary.wiley.com/doi/10.1002/1744-9987.70184?af=R}
}
ABSTRACT Approximately 5% of patients who develop renal rupture lack an identifiable underlying lesion, such as tumours, hydronephrosis, or vascular malformations. In this case report, we detail a case with a left renal rupture of a...
ABSTRACT Aim Both high and low body mass index (BMI) have been reported to be associated with a higher risk of chronic kidney disease (CKD) progression. However, whether this association varies across CKD stages remains unclear. We...
Nature Reviews Nephrology, Published online: 17 November 2026; doi:10.1038/s41581-026-01151-4 The concept of cardiovascular–kidney–metabolic (CKM) syndrome supports an integrated, multidisciplinary approach to improve patient outcomes....
ABSTRACT Introduction Patients on hemodialysis have an increased risk of sudden cardiac death and an increased cardiac arrhythmia burden due to large fluid and electrolyte shifts, especially during the long inter‐dialytic period....